Erratum: Reexamining neutrophil participation (Journal of the American Society of Nephrology (2017) 28: 8 (2275-2289) DOI: 10.1681/ASN.2016121271);Re-examining neutrophil participation in GN

Journal of the American Society of Nephrology

Volumn 28, Issue 8, 2017, Pages 2275-2289

  Caster, Dawn J ^a,b   Powell, David W ^a   Miralda, Irina ^a   Ward, Richard A ^a   McLeish, Kenneth R ^a,b  

^a University of Louisville School of Medicine   (United States)

^b VETERANS AFFAIRS MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

COMPLEMENT;

ADAPTIVE IMMUNITY; CELL HETEROGENEITY; CELL INTERACTION; CELL PLASTICITY; COMPLEMENT ACTIVATION; EXTRACELLULAR TRAP; GLOMERULONEPHRITIS; HUMAN; IMMUNOCOMPETENT CELL; INFLAMMATION; INNATE IMMUNITY; INTRACELLULAR KILLING; LEUKOCYTE FUNCTION; LEUKOCYTE MICROPARTICLE; NEUTROPHIL; NONHUMAN; PRIORITY JOURNAL; REVIEW; ANIMAL; IMMUNOLOGY; MICROBIOLOGY; NEUTROPHIL CHEMOTAXIS; PHYSIOLOGY;

ADAPTIVE IMMUNITY; ANIMALS; GLOMERULONEPHRITIS; HUMANS; IMMUNITY, INNATE; NEUTROPHIL INFILTRATION; NEUTROPHILS;

EID: 85026528193     PISSN: 10466673     EISSN: 15333450     Source Type: Journal    
DOI: 10.1681/ASN.2017080862     Document Type: Erratum

References (256)

1. Cochrane CG, Unanue ER, Dixon FJ: A role of polymorphonuclear leukocytes and complement in nephrotoxic nephritis. J ExpMed 122: 99-116, 1965
2. Sung SS, Bolton WK: T cells and dendritic cells in glomerular disease: The new glomerulotubular feedback loop. Kidney Int 77: 393-399, 2010
3. Rood IM, Hofstra JM, Deegens JK, Wetzels JF: B cell suppression in primary glomerular disease. Adv Chronic Kidney Dis 21: 166-181, 2014
4. Nauseef WM, Borregaard N: Neutrophils at work. Nat Immunol 15: 602-611, 2014
5. Jaillon S, Galdiero MR, Del Prete D, Cassatella MA, Garlanda C, Mantovani A: Neutrophils in innate and adaptive immunity. Semin Immunopathol 35: 377-394, 2013
6. Radic M, Marion TN: Neutrophil extracellular chromatin traps connect innate immune response to autoimmunity. Semin Immunopathol 35: 465-480, 2013
7. Witko-Sarsat V, Rieu P, Descamps-Latscha B, Lesavre P, Halbwachs-Mecarelli L: Neutrophils: Molecules, functions and pathophysiological aspects. Lab Invest 80: 617-653, 2000
8. Takeuchi O, Akira S: Pattern recognition receptors and inflammation. Cell 140: 805-820, 2010
9. Sadik CD, Kim ND, Luster AD: Neutrophils cascading their way to inflammation. Trends Immunol 32: 452-460, 2011
10. Marki A, Esko JD, Pries AR, Ley K: Role of the endothelial surface layer in neutrophil recruitment. J Leukoc Biol 98: 503-515, 2015
11. Zarbock A, Ley K, McEver RP, Hidalgo A: Leukocyte ligands for endothelial selectins: Specialized glycoconjugates that mediate rolling and signaling under flow. Blood 118: 6743-6751, 2011
12. Kolaczkowska E, Kubes P: Neutrophil recruitment and function in health and inflammation. Nat Rev Immunol 13: 159-175, 2013
13. Sundd P, Pospieszalska MK, Ley K: Neutrophil rolling at high shear: Flattening, catch bond behavior, tethers and slings. Mol Immunol 55: 59-69, 2013
14. Schmidt S, Moser M, Sperandio M: The molecular basis of leukocyte recruitment and its deficiencies. Mol Immunol 55: 49-58, 2013
15. Jones DH, Anderson DC, Burr BL, Rudloff HE, Smith CW, Krater SS, Schmalstieg FC: Quantitation of intracellular Mac-1 (CD11b/ CD18) pools in human neutrophils. J Leukoc Biol 44: 535-544, 1988
16. Molad Y, Haines KA, Anderson DC, Buyon JP, Cronstein BN: Immunocomplexes stimulate different signalling events to chemoattractants in the neutrophil and regulate L-selectin and beta 2-integrin expression differently. Biochem J 299: 881-887, 1994
17. Phillipson M, Heit B, Colarusso P, Liu L, Ballantyne CM, Kubes P: Intraluminal crawling of neutrophils to emigration sites: A molecularly distinct process from adhesion in the recruitment cascade. J ExpMed 203: 2569-2575, 2006
18. Reichel CA, Rehberg M, Bihari P, Moser CM, Linder S, Khandoga A, Krombach F: Gelatinases mediate neutrophil recruitment in vivo: Evidence for stimulus specificity and a critical role in collagen IV remodeling. J Leukoc Biol 83: 864-874, 2008
19. Foxman EF, Campbell JJ, Butcher EC: Multistep navigation and the combinatorial control of leukocyte chemotaxis. J Cell Biol 139: 1349-1360, 1997
20. Foxman EF, Kunkel EJ, Butcher EC: Integrating conflicting chemotactic signals. The role ofmemory in leukocyte navigation. J Cell Biol 147: 577-588, 1999
21. Lämmermann T, Afonso PV, Angermann BR, Wang JM, Kastenmüller W, Parent CA, Germain RN: Neutrophil swarms require LTB4 and integrins at sites of cell death in vivo. Nature 498: 371-375, 2013
22. Németh T, Mócsai A: Feedback Amplification of Neutrophil Function. Trends Immunol 37: 412-424, 2016
23. Kuligowski MP, Kitching AR, Hickey MJ: Leukocyte recruitment to the inflamed glomerulus: a critical role for platelet-derived P-selectin in the absence of rolling. J Immunol 176: 6991-6999, 2006
24. Coxon A, Cullere X, Knight S, Sethi S, Wakelin MW, Stavrakis G, Luscinskas FW, Mayadas TN: Fc gamma RIII mediates neutrophil recruitment to immune complexes. a mechanism for neutrophil accumulation in immune-mediated inflammation. Immunity 14: 693-704, 2001
25. Devi S, Kuligowski MP, Kwan RY, Westein E, Jackson SP, Kitching AR, Hickey MJ: Platelet recruitment to the inflamed glomerulus occurs via an alphaIIbbeta3/GPVI-dependent pathway. Am J Pathol 177: 1131-1142, 2010
26. Devi S, Li A, Westhorpe CL, Lo CY, Abeynaike LD, Snelgrove SL, Hall P, Ooi JD, Sobey CG, Kitching AR, Hickey MJ: Multiphoton imaging reveals a new leukocyte recruitment paradigm in the glomerulus. Nat Med 19: 107-112, 2013
27. Tipping PG, Huang XR, Berndt MC, Holdsworth SR: A role for P selectin in complement-independent neutrophilmediated glomerular injury. Kidney Int 46: 79-88, 1994
28. Tang T, Rosenkranz A, Assmann KJ, Goodman MJ, Gutierrez-Ramos JC, Carroll MC, Cotran RS, Mayadas TN:Arole forMac-1(CDIIb/CD18) in immune complex-stimulated neutrophil function in vivo: Mac-1 deficiency abrogates sustained Fcgamma receptor-dependent neutrophil adhesion and complementdependent proteinuria in acute glomerulonephritis. J ExpMed 186: 1853-1863, 1997
29. Wakayama H, Hasegawa Y, Kawabe T, Hara T, Matsuo S, Mizuno M, Takai T, Kikutani H, Shimokata K: Abolition of anti-glomerular basement membrane antibody-mediated glomerulonephritis in FcRgamma-deficient mice. Eur J Immunol 30: 1182-1190, 2000
30. Rosetti F, Tsuboi N, Chen K, Nishi H, Ernandez T, Sethi S, Croce K, Stavrakis G, Alcocer-Varela J, Gómez-Martin D, van Rooijen N, Kyttaris VC, Lichtman AH, Tsokos GC, Mayadas TN: Human lupus serum induces neutrophil-mediated organ damage in mice that is enabled by Mac-1 deficiency. J Immunol 189: 3714-3723, 2012
31. De Vriese AS, Endlich K, Elger M, Lameire NH, Atkins RC, Lan HY, Rupin A, Kriz W, Steinhausen MW: The role of selectins in glomerular leukocyte recruitment in rat anti-glomerular basement membrane glomerulonephritis. J Am Soc Nephrol 10: 2510-2517, 1999
32. Rosenkranz AR, Mendrick DL, Cotran RS, Mayadas TN: P-selectin deficiency exacerbates experimental glomerulonephritis: A protective role for endothelial P-selectin in inflammation. J Clin Invest 103: 649-659, 1999
33. Finsterbusch M, Hall P, Li A, Devi S, Westhorpe CL, Kitching AR, Hickey MJ: Patrolling monocytes promote intravascular neutrophil activation and glomerular injury in the acutely inflamed glomerulus. Proc Natl Acad Sci USA 113: E5172-E5181, 2016
34. Tipping PG, Boyce NW, Holdsworth SR: Relative contributions of chemo-attractant and terminal components of complement to anti-glomerular basement membrane (GBM) glomerulonephritis. Clin Exp Immunol 78: 444-448, 1989
35. Huang XR, Holdsworth SR, Tipping PG: Th2 responses induce humorally mediated injury in experimental anti-glomerular basement membrane glomerulonephritis. J Am Soc Nephrol 8: 1101-1108, 1997
36. Hébert MJ, Takano T, Papayianni A, Rennke HG, Minto A, Salant DJ, Carroll MC, Brady HR: Acute nephrotoxic serum nephritis in complement knockout mice: relative roles of the classical and alternate pathways in neutrophil recruitment and proteinuria. Nephrol Dial Transplant 13: 2799-2803, 1998
37. Trendelenburg M, Fossati-Jimack L, Cortes-Hernandez J, Turnberg D, Lewis M, Izui S, Cook HT, Botto M: The role of complement in cryoglobulin-induced immune complex glomerulonephritis. J Immunol 175: 6909-6914, 2005
38. Xiao H, Schreiber A, Heeringa P, Falk RJ, Jennette JC: Alternative complement pathway in the pathogenesis of disease mediated by anti-neutrophil cytoplasmic autoantibodies. Am J Pathol 170: 52-64, 2007
39. Xiao H, Dairaghi DJ, Powers JP, Ertl LS, Baumgart T, Wang Y, Seitz LC, Penfold ME, Gan L, Hu P, Lu B, Gerard NP, Gerard C, Schall TJ, Jaen JC, Falk RJ, Jennette JC: C5a receptor (CD88) blockade protects againstMPO-ANCA GN. J AmSoc Nephrol 25: 225-231, 2014
40. Schreiber A, Xiao H, Jennette JC, Schneider W, Luft FC, Kettritz R: C5a receptor mediates neutrophil activation and ANCA-induced glomerulonephritis. J Am Soc Nephrol 20: 289-298, 2009
41. Ewert BH, Becker ME, Jennette JC, Falk RJ: Antimyeloperoxidase antibodies induce neutrophil adherence to cultured human endothelial cells. Ren Fail 17: 125-133, 1995
42. Lu X, Garfield A, Rainger GE, Savage CO, Nash GB: Mediation of endothelial cell damage by serine proteases, but not superoxide, released from antineutrophil cytoplasmic antibody-stimulated neutrophils. Arthritis Rheum 54: 1619-1628, 2006
43. Gou SJ, Yuan J, Chen M, Yu F, Zhao MH: Circulating complement activation in patients with anti-neutrophil cytoplasmic antibody- associated vasculitis. Kidney Int 83: 129-137, 2013
44. Nauseef WM: How human neutrophils kill and degrade microbes: An integrated view. Immunol Rev 219: 88-102, 2007
45. Murray J, Barbara JA, Dunkley SA, Lopez AF, VanOstade X, Condliffe AM, Dransfield I, Haslett C, Chilvers ER: Regulation of neutrophil apoptosis by tumor necrosis factor-alpha: requirement for TNFR55 and TNFR75 for induction of apoptosis in vitro. Blood 90: 2772-2783, 1997
46. Ward RA, Nakamura M, McLeish KR: Priming of the neutrophil respiratory burst involves p38 mitogen-activated protein kinasedependent exocytosis of flavocytochrome b558-containing granules. J Biol Chem275: 36713-36719, 2000
47. Lauterbach M, O'Donnell P, Asano K, Mayadas TN: Role of TNF priming and adhesion molecules in neutrophil recruitment to intravascular immune complexes. J Leukoc Biol 83: 1423-1430, 2008
48. Volk AP, Barber BM, Goss KL, Ruff JG, Heise CK, Hook JS, Moreland JG: Priming of neutrophils and differentiated PLB-985 cells by pathophysiological concentrations of TNF-a is partially oxygen dependent. J Innate Immun 3: 298-314, 2011
49. Kallenberg CG, Heeringa P, Stegeman CA: Mechanisms of Disease: Pathogenesis and treatment of ANCA-associated vasculitides. Nat Clin Pract Rheumatol 2: 661-670, 2006
50. Donovan KL, Coles GA, Williams JD: Tumor necrosis factor-alpha augments the pro-inflammatory interaction between PMN and GBM via a CD18 dependent mechanism. Kidney Int 48: 698-704, 1995
51. Suzuki Y, Gómez-Guerrero C, Shirato I, López-Franco O, Gallego-Delgado J, Sanjuán G, Lázaro A, Hernández-Vargas P, Okumura K, Tomino Y, Ra C, Egido J: Preexisting glomerular immune complexes induce polymorphonuclear cell recruitment through an Fc receptor-dependent respiratory burst: Potential role in the perpetuation of immune nephritis. J Immunol 170: 3243-3253, 2003
52. Feith GW, Assmann KJ, Bogman MJ, van Gompel AP, Schalkwijk J, Koene RA: Different mediator systems in biphasic heterologous phase of anti-GBM nephritis in mice. Nephrol Dial Transplant 11: 599-607, 1996
53. Li JZ, Sharma R, Dileepan KN, Savin VJ: Polymorphonuclear leukocytes increase glomerular albumin permeability via hypohalous acid. Kidney Int 46: 1025-1030, 1994
54. Johnson RJ, Couser WG, Chi EY, Adler S, Klebanoff SJ: New mechanism for glomerular injury. Myeloperoxidase-hydrogen peroxide-halide system. J Clin Invest 79: 1379-1387, 1987
55. Odobasic D, Kitching AR, Semple TJ, Holdsworth SR: Endogenous myeloperoxidase promotes neutrophil-mediated renal injury, but attenuates T cell immunity inducing crescentic glomerulonephritis. J Am Soc Nephrol 18: 760-770, 2007
56. Schreiber A, Luft FC, Kettritz R: Phagocyte NADPH oxidase restrains the inflammasome in ANCA-induced GN. J Am Soc Nephrol 26: 411-424, 2015
57. Lominadze G, Powell DW, Luerman GC, Link AJ, Ward RA, McLeish KR: Proteomic analysis of human neutrophil granules. Mol Cell Proteomics 4: 1503-1521, 2005
58. Uriarte SM, Powell DW, Luerman GC, Merchant ML, Cummins TD, Jog NR, Ward RA, McLeish KR: Comparison of proteins expressed on secretory vesicle membranes and plasma membranes of human neutrophils. J Immunol 180: 5575-5581, 2008
59. Kain R, Matsui K, Exner M, Binder S, Schaffner G, Sommer EM, Kerjaschki D: A novel class of autoantigens of anti-neutrophil cytoplasmic antibodies in necrotizing and crescentic glomerulonephritis: The lysosomal membrane glycoprotein h-lamp-2 in neutrophil granulocytes and a related membrane protein in glomerular endothelial cells. J ExpMed 181: 585-597, 1995
60. Falk RJ, Terrell RS, Charles LA, Jennette JC: Anti-neutrophil cytoplasmic autoantibodies induce neutrophils to degranulate and produce oxygen radicals in vitro. Proc Natl Acad Sci USA 87: 4115-4119, 1990
61. Kettritz R: How anti-neutrophil cytoplasmic autoantibodies activate neutrophils. Clin Exp Immunol 169: 220-228, 2012
62. Mulder AH, Heeringa P, Brouwer E, Limburg PC, Kallenberg CG: Activation of granulocytes by anti-neutrophil cytoplasmic antibodies (ANCA): A Fc gamma RIIdependent process. Clin Exp Immunol 98: 270-278, 1994
63. Kettritz R, Jennette JC, Falk RJ: Crosslinking of ANCA-antigens stimulates superoxide release by human neutrophils. J Am Soc Nephrol 8: 386-394, 1997
64. Xiao H, Heeringa P, Liu Z, Huugen D, Hu P, Maeda N, Falk RJ, Jennette JC: The role of neutrophils in the induction of glomerulonephritis by anti-myeloperoxidase antibodies. Am J Pathol 167: 39-45, 2005
65. Schreiber A, Luft FC, Kettritz R: Membrane proteinase 3 expression and ANCAinduced neutrophil activation. Kidney Int 65: 2172-2183, 2004
66. Schreiber A, Pham CT, Hu Y, Schneider W, Luft FC, Kettritz R: Neutrophil serine proteases promote IL-1b generation and injury in necrotizing crescentic glomerulonephritis. J Am Soc Nephrol 23: 470-482, 2012
67. Schrijver G, Schalkwijk J, Robben JC, Assmann KJ, Koene RA: Antiglomerular basement membrane nephritis in beige mice. Deficiency of leukocytic neutral proteinases prevents the induction of albuminuria in the heterologous phase. J Exp Med 169: 1435-1448, 1989
68. Suzuki S, Gejyo F, Kuroda T, Kazama JJ, Imai N, Kimura H, Arakawa M: Effects of a novel elastase inhibitor, ONO-5046, on nephrotoxic serum nephritis in rats. Kidney Int 53: 1201-1208, 1998
69. Davies M, Barrett AJ, Travis J, Sanders E, Coles GA: The degradation of human glomerular basement membrane with purified lysosomal proteinases: Evidence for the pathogenic role of the polymorphonuclear leucocyte in glomerulonephritis. Clin Sci Mol Med 54: 233-240, 1978
70. Kuźniar J, Kuźniar TJ, Marchewka Z, Lembas-Bogaczyk J, Rabczyński J, Kopeć W, Klinger M: Elastase deposits in the kidney and urinary elastase excretion in patientswith glomerulonephritis-Evidence for neutrophil involvement in renal injury. Scand J Urol Nephrol 41: 527-534, 2007
71. Oda T, Hotta O, Taguma Y, Kitamura H, Sudo K, Horigome I, Chiba S, Yoshizawa N, Nagura H: Involvement of neutrophil elastase in crescentic glomerulonephritis. Hum Pathol 28: 720-728, 1997
72. Sanders JS, van Goor H, Hanemaaijer R, Kallenberg CG, Stegeman CA: Renal expression of matrix metalloproteinases in human ANCA-associated glomerulonephritis. Nephrol Dial Transplant 19: 1412-1419, 2004
73. Sharma R, Suzuki K, Nagase H, Savin VJ: Matrix metalloproteinase (stromelysin-1) increases the albumin permeability of isolated rat glomeruli. J Lab Clin Med 128: 297-303, 1996
74. Rørvig S, Østergaard O, Heegaard NH, Borregaard N: Proteome profiling of human neutrophil granule subsets, secretory vesicles, and cell membrane: Correlation with transcriptome profiling of neutrophil precursors. J Leukoc Biol 94: 711-721, 2013
75. Soehnlein O, Weber C, Lindbom L: Neutrophil granule proteins tune monocytic cell function. Trends Immunol 30: 538-546, 2009
76. Yang D, de la Rosa G, Tewary P, Oppenheim JJ: Alarmins link neutrophils and dendritic cells. Trends Immunol 30: 531-537, 2009
77. Borregaard N, Sørensen OE, Theilgaard-Mönch K: Neutrophil granules: A library of innate immunity proteins. Trends Immunol 28: 340-345, 2007
78. DiStasi MR, Ley K: Opening the flood-gates: How neutrophil-endothelial interactions regulate permeability. Trends Immunol 30: 547-556, 2009
79. Pham CT: Neutrophil serine proteases: Specific regulators of inflammation. Nat Rev Immunol 6: 541-550, 2006
80. Pillay J, den Braber I, Vrisekoop N, Kwast LM, de Boer RJ, Borghans JA, Tesselaar K, Koenderman L: In vivo labeling with 2H2O reveals a human neutrophil lifespan of 5.4 days. Blood 116: 625-627, 2010
81. Lahoz-Beneytez J, Elemans M, Zhang Y, Ahmed R, Salam A, Block M, Niederalt C, Asquith B, Macallan D: Human neutrophil kinetics: Modeling of stable isotope labeling data supports short blood neutrophil half-lives. Blood 127: 3431-3438, 2016
82. McCracken JM, Allen LA: Regulation of human neutrophil apoptosis and lifespan in health and disease. J Cell Death 7: 15-23, 2014
83. Hughes J, Johnson RJ, Mooney A, Hugo C, Gordon K, Savill J: Neutrophil fate in experimental glomerular capillary injury in the rat. Emigration exceeds in situ clearance by apoptosis. Am J Pathol 150: 223-234, 1997
84. Scapini P, Cassatella MA: Social networking of human neutrophils within the immune system. Blood 124: 710-719, 2014
85. Silvestre-Roig C, Hidalgo A, Soehnlein O: Neutrophil heterogeneity: implications for homeostasis and pathogenesis. Blood 127: 2173-2181, 2016
86. Bowers NL, Helton ES, Huijbregts RP, Goepfert PA, Heath SL, Hel Z: Immune suppression by neutrophils in HIV-1 infection: Role of PD-L1/PD-1 pathway. PLoS Pathog 10: e1003993, 2014
87. Cloke T, Munder M, Bergin P, Herath S, Modolell M, Taylor G, Müller I, Kropf P: Phenotypic alteration of neutrophils in the blood of HIV seropositive patients. PLoS One 8: e72034, 2013
88. Sagiv JY, Michaeli J, Assi S, Mishalian I, Kisos H, Levy L, Damti P, Lumbroso D, Polyansky L, Sionov RV, Ariel A, Hovav AH, Henke E, Fridlender ZG, Granot Z: Phenotypic diversity and plasticity in circulating neutrophil subpopulations in cancer. Cell Reports 10: 562-573, 2015
89. Amirbeagi F, Thulin P, Pullerits R, Pedersen B, Andersson BA, Dahlgren C, Welin A, Bylund J: Olfactomedin-4 autoantibodies give unusual c-ANCA staining patterns with reactivity to a subpopulation of neutrophils. J Leukoc Biol 97: 181-189, 2015
90. Hu N, Mora-Jensen H, Theilgaard-Mönch K, Doornbos-van der Meer B, Huitema MG, Stegeman CA, Heeringa P, Kallenberg CG, Westra J: Differential expression of granulopoiesis related genes in neutrophil subsets distinguished bymembrane expression of CD177. PLoS One 9: e99671, 2014
91. Dumitru CA, Moses K, Trellakis S, Lang S, Brandau S: Neutrophils and granulocytic myeloid-derived suppressor cells: Immunophenotyping, cell biology and clinical relevance in human oncology. Cancer Immunol Immunother 61: 1155-1167, 2012
92. Carmona-Rivera C, Kaplan MJ: Low-density granulocytes: A distinct class of neutrophils in systemic autoimmunity. Semin Immunopathol 35: 455-463, 2013
93. Ssemaganda A, Kindinger L, Bergin P, Nielsen L, Mpendo J, Ssetaala A, Kiwanuka N, Munder M, Teoh TG, Kropf P, Müller I: Characterization of neutrophil subsets in healthy human pregnancies. PLoS One 9: e85696, 2014
94. Brinkmann V, Reichard U, Goosmann C, Fauler B, Uhlemann Y, Weiss DS, Weinrauch Y, Zychlinsky A: Neutrophil extracellular traps kill bacteria. Science 303: 1532-1535, 2004
95. Neeli I, Khan SN, Radic M: Histone deimination as a response to inflammatory stimuli in neutrophils. J Immunol 180: 1895-1902, 2008
96. Martinelli S, Urosevic M, Daryadel A, Oberholzer PA, Baumann C, Fey MF, Dummer R, Simon HU, Yousefi S: Induction of genes mediating interferon-dependent extracellular trap formation during neutrophil differentiation. J Biol Chem 279: 44123-44132, 2004
97. Munks MW, McKee AS, Macleod MK, Powell RL, Degen JL, Reisdorph NA, Kappler JW, Marrack P: Aluminum adjuvants elicit fibrin-dependent extracellular traps in vivo. Blood 116: 5191-5199, 2010
98. Papayannopoulos V, Zychlinsky A: NETs: A new strategy for using old weapons. Trends Immunol 30: 513-521, 2009
99. Brinkmann V, Zychlinsky A: Neutrophil extracellular traps: Is immunity the second function of chromatin? J Cell Biol 198: 773-783, 2012
100. Sørensen OE, Borregaard N: Neutrophil extracellular traps - The dark side of neutrophils. JClin Invest 126: 1612-1620, 2016
101. Gupta S, Kaplan MJ: The role of neutrophils and NETosis in autoimmune and renal diseases. Nat Rev Nephrol 12: 402-413, 2016
102. Kessenbrock K, Krumbholz M, Schönermarck U, Back W, Gross WL, Werb Z, Gröne HJ, Brinkmann V, Jenne DE: Netting neutrophils in autoimmune small-vessel vasculitis. Nat Med 15: 623-625, 2009
103. Yoshida M, Sasaki M, Sugisaki K, Yamaguchi Y, Yamada M: Neutrophil extracellular trap components in fibrinoid necrosis of the kidney with myeloperoxidase-ANCAassociated vasculitis. Clin Kidney J 6: 308-312, 2013
104. Westhorpe CL, Bayard JE, O'Sullivan KM, Hall P, Cheng Q, Kitching AR, Hickey MJ: In Vivo imaging of inflamed glomeruli reveals dynamics of neutrophil extracellular trap formation in glomerular capillaries. Am J Pathol 187: 318-331, 2017
105. Craft JE: Dissecting the immune cell mayhem that drives lupus pathogenesis. Sci Transl Med 3: 73ps9, 2011
106. Garcia-Romo GS, Caielli S, Vega B, Connolly J, Allantaz F, Xu Z, Punaro M, Baisch J, Guiducci C, Coffman RL, Barrat FJ, Banchereau J, Pascual V: Netting neutrophils are major inducers of type I IFN production in pediatric systemic lupus erythematosus. Sci Transl Med 3: 73ra20, 2011
107. Lande R, Ganguly D, Facchinetti V, Frasca L, Conrad C, Gregorio J, Meller S, Chamilos G, Sebasigari R, Riccieri V, Bassett R, Amuro H, Fukuhara S, Ito T, Liu YJ, Gilliet M: Neutrophils activate plasmacytoid dendritic cells by releasing self-DNA-peptide complexes in systemic lupus erythematosus. Sci Transl Med 3: 73ra19, 2011
108. Villanueva E, Yalavarthi S, Berthier CC, Hodgin JB, Khandpur R, Lin AM, Rubin CJ, Zhao W, Olsen SH, Klinker M, Shealy D, Denny MF, Plumas J, Chaperot L, Kretzler M, Bruce AT, Kaplan MJ: Netting neutrophils induce endothelial damage, infiltrate tissues, and expose immunostimulatory molecules in systemic lupus erythematosus. J Immunol 187: 538-552, 2011
109. Tillack K, Breiden P, Martin R, Sospedra M: T lymphocyte priming by neutrophil extracellular traps links innate and adaptive immune responses. J Immunol 188: 3150-3159, 2012
110. Hakkim A, Fürnrohr BG, Amann K, Laube B, Abed UA, Brinkmann V, Herrmann M, Voll RE, Zychlinsky A: Impairment of neutrophil extracellular trap degradation is associated with lupus nephritis. Proc Natl Acad Sci USA 107: 9813-9818, 2010
111. Leffler J, Martin M, Gullstrand B, Tydén H, Lood C, Truedsson L, Bengtsson AA, Blom AM: Neutrophil extracellular traps that are not degraded in systemic lupus erythematosus activate complement exacerbating the disease. J Immunol 188: 3522-3531, 2012
112. Timár CI, Lorincz AM, Csépányi-Kömi R, Vályi-Nagy A, Nagy G, Buzás EI, Iványi Z, Kittel A, Powell DW, McLeish KR, Ligeti E: Antibacterial effect of microvesicles released from human neutrophilic granulocytes. Blood 121: 510-518, 2013
113. Gasser O, Schifferli JA: Activated polymorphonuclear neutrophils disseminate anti-inflammatory microparticles by ectocytosis. Blood 104: 2543-2548, 2004
114. Prakash PS, Caldwell CC, Lentsch AB, Pritts TA, Robinson BR: Human microparticles generated during sepsis in patients with critical illness are neutrophil-derived and modulate the immune response. J Trauma Acute Care Surg 73: 401-406, discussion 406-407, 2012
115. Myers DD, Hawley AE, Farris DM, Wrobleski SK, Thanaporn P, Schaub RG, Wagner DD, Kumar A, Wakefield TW: P-selectin and leukocyte microparticles are associated with venous thrombogenesis. J Vasc Surg 38: 1075-1089, 2003
116. Daniel L, Fakhouri F, Joly D, Mouthon L, Nusbaum P, Grunfeld JP, Schifferli J, Guillevin L, Lesavre P, Halbwachs-Mecarelli L: Increase of circulating neutrophil and platelet microparticles during acute vasculitis and hemodialysis. Kidney Int 69: 1416-1423, 2006
117. Hong Y, Eleftheriou D, Hussain AA, Price-Kuehne FE, Savage CO, Jayne D, Little MA, Salama AD, Klein NJ, Brogan PA: Antineutrophil cytoplasmic antibodies stimulate release of neutrophil microparticles. J Am Soc Nephrol 23: 49-62, 2012
118. Vikerfors A, Mobarrez F, Bremme K, Holmström M, Ågren A, Eelde A, Bruzelius M, Antovic A, Wallén H, Svenungsson E: Studies of microparticles in patients with the antiphospholipid syndrome (APS). Lupus 21: 802-805, 2012
119. Dignat-George F, Camoin-Jau L, Sabatier F, Arnoux D, Anfosso F, Bardin N, Veit V, Combes V, Gentile S, Moal V, Sanmarco M, Sampol J: Endothelial microparticles: A potential contribution to the thrombotic complications of the antiphospholipid syndrome. Thromb Haemost 91: 667-673, 2004
120. Sellam J, Proulle V, Jüngel A, Ittah M, Miceli Richard C, Gottenberg JE, Toti F, Benessiano J, Gay S, Freyssinet JM, Mariette X: Increased levels of circulating microparticles in primary Sjögren's syndrome, systemic lupus erythematosus and rheumatoid arthritis and relation with disease activity. Arthritis Res Ther 11: R156, 2009
121. Nielsen CT, Østergaard O, Johnsen C, Jacobsen S, Heegaard NH:Distinct features of circulating microparticles and their relationship to clinical manifestations in systemic lupus erythematosus. Arthritis Rheum 63: 3067-3077, 2011
122. Pisetsky DS, Gauley J, Ullal AJ: Microparticles as a source of extracellular DNA. Immunol Res 49: 227-234, 2011
123. Nielsen CT, Østergaard O, Stener L, Iversen LV, Truedsson L, Gullstrand B, Jacobsen S, Heegaard NH: Increased IgG on cell-derived plasma microparticles in systemic lupus erythematosus is associated with autoantibodies and complement activation. Arthritis Rheum 64: 1227-1236, 2012
124. Ullal AJ, Reich CF 3rd, Clowse M, Criscione-Schreiber LG, Tochacek M, Monestier M, Pisetsky DS: Microparticles as antigenic targets of antibodies to DNA and nucleosomes in systemic lupus erythematosus. J Autoimmun 36: 173-180, 2011
125. Tecchio C, Micheletti A, Cassatella MA: Neutrophil-derived cytokines: Facts beyond expression. Front Immunol 5: 508, 2014
126. Tecchio C, Cassatella MA: Neutrophil-derived chemokines on the road to immunity. Semin Immunol 28: 119-128, 2016
127. David A, Kacher Y, Specks U, Aviram I: Interaction of proteinase 3 with CD11b/CD18 (beta2 integrin) on the cell membrane of human neutrophils. J Leukoc Biol 74: 551-557, 2003
128. Soehnlein O, Oehmcke S, Ma X, Rothfuchs AG, Frithiof R, van Rooijen N, Mörgelin M, Herwald H, Lindbom L: Neutrophil degranulation mediates severe lung damage triggered by streptococcal M1 protein. Eur Respir J 32: 405-412, 2008
129. Soehnlein O, Xie X, Ulbrich H, Kenne E, Rotzius P, Flodgaard H, Eriksson EE, Lindbom L: Neutrophil-derived heparinbinding protein (HBP/CAP37) deposited on endothelium enhances monocyte arrest under flow conditions. J Immunol 174: 6399-6405, 2005
130. Taekema-Roelvink ME, Kooten C, Kooij SV, Heemskerk E, Daha MR: Proteinase 3 enhances endothelial monocyte chemoattractant protein-1 production and induces increased adhesion of neutrophils to endothelial cells by upregulating intercellular cell adhesion molecule-1. J Am Soc Nephrol 12: 932-940, 2001
131. Tjabringa GS, Aarbiou J, Ninaber DK, Drijfhout JW, Sørensen OE, Borregaard N, Rabe KF, Hiemstra PS: The antimicrobial peptide LL-37 activates innate immunity at the airway epithelial surface by transactivation of the epidermal growth factor receptor. J Immunol 171: 6690-6696, 2003
132. Di Gennaro A, Kenne E, Wan M, Soehnlein O, Lindbom L, Haeggström JZ: Leukotriene B4-induced changes in vascular permeability are mediated by neutrophil release of heparin-binding protein (HBP/CAP37/ azurocidin). FASEB J 23: 1750-1757, 2009
133. Gautam N, Olofsson AM, Herwald H, Iversen LF, Lundgren-Akerlund E, Hedqvist P, Arfors KE, Flodgaard H, Lindbom L: Heparin-binding protein (HBP/CAP37): A missing link in neutrophil-evoked alteration of vascular permeability. Nat Med 7: 1123-1127, 2001
134. Akashi-Takamura S, Miyake K: TLR accessory molecules. Curr Opin Immunol 20: 420-425, 2008
135. Davidson DJ, Currie AJ, Reid GS, Bowdish DM, MacDonald KL, Ma RC, Hancock RE, Speert DP: The cationic antimicrobial peptide LL-37 modulates dendritic cell differentiation and dendritic cell-induced T cell polarization. J Immunol 172: 1146-1156, 2004
136. Yang D, Chen Q, Chertov O, Oppenheim JJ: Human neutrophil defensins selectively chemoattract naive T and immature dendritic cells. J Leukoc Biol 68: 9-14, 2000
137. de la Rosa G, Yang D, Tewary P, Varadhachary A, Oppenheim JJ: Lactoferrin acts as an alarmin to promote the recruitment and activation of APCs and antigen-specific immune responses. J Immunol 180: 6868-6876, 2008
138. Müller I, Munder M, Kropf P, Hänsch GM: Polymorphonuclear neutrophils and T lymphocytes: Strange bedfellows or brothers in arms? Trends Immunol 30: 522-530, 2009
139. Costantini C, Cassatella MA: The defensive alliance between neutrophils and NK cells as a novel arm of innate immunity. J Leukoc Biol 89: 221-233, 2011
140. Pelletier M, Maggi L, Micheletti A, Lazzeri E, Tamassia N, Costantini C, Cosmi L, Lunardi C, Annunziato F, Romagnani S, Cassatella MA: Evidence for a cross-talk between human neutrophils and Th17 cells. Blood 115: 335-343, 2010
141. Bhatnagar N, Hong HS, Krishnaswamy JK, Haghikia A, Behrens GM, Schmidt RE, Jacobs R: Cytokine-activated NK cells inhibit PMN apoptosis and preserve their functional capacity. Blood 116: 1308-1316, 2010
142. Costantini C, Micheletti A, Calzetti F, Perbellini O, Pizzolo G, Cassatella MA: Neutrophil activation and survival are modulated by interaction with NK cells. Int Immunol 22: 827-838, 2010
143. Scapini P, Lapinet-Vera JA, Gasperini S, Calzetti F, Bazzoni F, Cassatella MA: The neutrophil as a cellular source of chemokines. Immunol Rev 177: 195-203, 2000
144. Jones HR, Robb CT, Perretti M, Rossi AG: The role of neutrophils in inflammation resolution. Semin Immunol 28: 137-145, 2016
145. Serhan CN, Chiang N, Van Dyke TE: Resolving inflammation: dual anti-inflammatory and pro-resolution lipid mediators. Nat Rev Immunol 8: 349-361, 2008
146. Wu SH, Liao PY, Yin PL, Zhang YM, Dong L: Elevated expressions of 15-lipoxygenase and lipoxin A4 in children with acute poststreptococcal glomerulonephritis. Am J Pathol 174: 115-122, 2009
147. McMahon B, Mitchell D, Shattock R, Martin F, Brady HR, Godson C: Lipoxin, leukotriene, and PDGF receptors cross-talk to regulate mesangial cell proliferation. FASEB J 16: 1817-1819, 2002
148. Ohse T, Ota T, Kieran N, Godson C, Yamada K, Tanaka T, Fujita T, Nangaku M: Modulation of interferon-induced genes by lipoxin analogue in anti-glomerular basement membrane nephritis. J Am Soc Nephrol 15: 919-927, 2004
149. Uriarte SM, Rane MJ, Merchant ML, Jin S, Lentsch AB, Ward RA, McLeish KR: Inhibition of neutrophil exocytosis ameliorates acute lung injury in rats. Shock 39: 286-292, 2013
150. Johnson JL, Ramadass M, He J, Brown SJ, Zhang J, Abgaryan L, Biris N, Gavathiotis E, Rosen H, Catz SD: Identification of neutrophil exocytosis inhibitors (Nexinhibs), small molecule inhibitors of neutrophil exocytosis and inflammation: DRUGGABILITY OF THE SMALL GTPase Rab27a. J Biol Chem 291: 25965-25982, 2016
151. Barletta KE, Ley K, Mehrad B: Regulation of neutrophil function by adenosine. Arterioscler Thromb Vasc Biol 32: 856-864, 2012
152. Futosi K, Fodor S, Mócsai A: Neutrophil cell surface receptors and their intracellular signal transduction pathways. Int Immunopharmacol 17: 638-650, 2013
153. Favier B: Regulation of neutrophil functions through inhibitory receptors: An emerging paradigm in health and disease. Immunol Rev 273: 140-155, 2016
154. Devarapu SK, Kumar Vr S, Rupanagudi KV, Kulkarni OP, Eulberg D, Klussmann S, Anders HJ: Dual blockade of the pro-inflammatory chemokine CCL2 and the homeostatic chemokine CXCL12 is as effective as high dose cyclophosphamide in murine proliferative lupus nephritis. Clin Immunol 169: 139-147, 2016
155. Ohlsson S, Bakoush O, Tencer J, Torffvit O, Segelmark M: Monocyte chemoattractant protein 1 is a prognostic marker in ANCAassociated small vessel vasculitis. Mediators Inflamm 2009: 584916, 2009
156. Liu ZH, Chen SF, Zhou H, Chen HP, Li LS: Glomerular expression of C-C chemokines in different types of human crescentic glomerulonephritis. Nephrol Dial Transplant 18: 1526-1534, 2003
157. Abujam B, Cheekatla S, Aggarwal A: Urinary CXCL-10/IP-10 and MCP-1 as markers to assess activity of lupus nephritis. Lupus 22: 614-623, 2013
158. Turner JE, Paust HJ, Bennstein SB, Bramke P, Krebs C, Steinmetz OM, Velden J, Haag F, Stahl RA, Panzer U: Protective role for CCR5 in murine lupus nephritis. Am J Physiol Renal Physiol 302: F1503-F1515, 2012
159. Mamtani M, Rovin B, Brey R, Camargo JF, Kulkarni H, Herrera M, Correa P, Holliday S, Anaya JM, Ahuja SK: CCL3L1 gene-containing segmental duplications and polymorphisms in CCR5 affect risk of systemic lupus erythaematosus. Ann Rheum Dis 67: 1076-1083, 2008
160. Auer J, Bläss M, Schulze-Koops H, Russwurm S, Nagel T, Kalden JR, Röllinghoff M, Beuscher HU: Expression and regulation of CCL18 in synovial fluid neutrophils of patients with rheumatoid arthritis. Arthritis Res Ther 9: R94, 2007
161. Brix SR, Stege G, Disteldorf E, Hoxha E, Krebs C, Krohn S, Otto B, Klätschke K, Herden E, Heymann F, Lira SA, Tacke F, Wolf G, Busch M, Jabs WJ, Özcan F, Keller F, Beige J, Wagner K, Helmchen U, Noriega M, Wiech T, Panzer U, Stahl RA: CC chemokine ligand 18 in ANCA-associated crescenticGN.JAmSocNephrol 26: 2105-2117, 2015
162. Paust HJ, Turner JE, Riedel JH, Disteldorf E, Peters A, Schmidt T, Krebs C, Velden J, Mittrücker HW, Steinmetz OM, Stahl RA, Panzer U: Chemokines play a critical role in the cross-regulation of Th1 and Th17 immune responses in murine crescentic glomerulonephritis. Kidney Int 82: 72-83, 2012
163. Meng T, Li X, Ao X, Zhong Y, Tang R, Peng W, Yang J, Zou M, Zhou Q: Hemolytic Streptococcus may exacerbate kidney damage in IgA nephropathy through CCL20 response to the effect of Th17 cells. PLoS One 9: e108723, 2014
164. Summers SA, van der Veen BS, O'Sullivan KM, Gan PY, Ooi JD, Heeringa P, Satchell SC, Mathieson PW, Saleem MA, Visvanathan K, Holdsworth SR, Kitching AR: Intrinsic renal cell and leukocyte-derived TLR4 aggravate experimental anti-MPO glomerulonephritis. Kidney Int 78: 1263-1274, 2010
165. Zhao Y, Zhu L, Zhou T, Zhang Q, Shi S, Liu L, Lv J, Zhang H: Urinary CXCL1: A novel predictor of IgA nephropathy progression. PLoS One 10: e0119033, 2015
166. Imaizumi T, Aizawa T, Segawa C, Shimada M, Tsuruga K, Kawaguchi S, Matsumiya T, Yoshida H, Joh K, Tanaka H: Toll-like receptor 3 signaling contributes to the expression of a neutrophil chemoattractant, CXCL1 in human mesangial cells. Clin Exp Nephrol 19: 761-770, 2015
167. Disteldorf EM, Krebs CF, Paust HJ, Turner JE, Nouailles G, Tittel A, Meyer-Schwesinger C, Stege G, Brix S, Velden J, Wiech T, Helmchen U, Steinmetz OM, Peters A, Bennstein SB, Kaffke A, Llanto C, Lira SA, Mittrücker HW, Stahl RA, Kurts C, Kaufmann SH, Panzer U: CXCL5 drives neutrophil recruitment in TH17-mediated GN. J Am Soc Nephrol 26: 55-66, 2015
168. Wada T, Tomosugi N, Naito T, Yokoyama H, Kobayashi K, Harada A, Mukaida N, Matsushima K: Prevention of proteinuria by the administration of anti-interleukin 8 antibody in experimental acute immune complex-induced glomerulonephritis. J Exp Med 180: 1135-1140, 1994
169. Cockwell P, Brooks CJ, Adu D, Savage CO: Interleukin-8: A pathogenetic role in antineutrophil cytoplasmic autoantibody-associated glomerulonephritis. Kidney Int 55: 852-863, 1999
170. Worthmann K, Gueler F, von Vietinghoff S, Davalos-Mißlitz A, Wiehler F, Davidson A, Witte T, Haller H, Schiffer M, Falk CS, Schiffer L: Pathogenetic role of glomerular CXCL13 expression in lupus nephritis. Clin Exp Immunol 178: 20-27, 2014
171. Monach PA, Warner RL, Tomasson G, Specks U, Stone JH, Ding L, Fervenza FC, Fessler BJ, Hoffman GS, Iklé D, Kallenberg CG, Krischer J, Langford CA, Mueller M, Seo P, St Clair EW, Spiera R, Tchao N, Ytterberg SR, Johnson KJ, Merkel PA: Serum proteins reflecting inflammation, injury and repair as biomarkers of disease activity in ANCA-associated vasculitis. Ann Rheum Dis 72: 1342-1350, 2013
172. Lee HT, Shiao YM, Wu TH, Chen WS, Hsu YH, Tsai SF, Tsai CY: Serum BLC/CXCL13 concentrations and renal expression of CXCL13/CXCR5 in patients with systemic lupus erythematosus and lupus nephritis. J Rheumatol 37: 45-52, 2010
173. Kitching AR, Ru Huang X, Turner AL, Tipping PG, Dunn AR, Holdsworth SR: The requirement for granulocyte-macrophage colony-stimulating factor and granulocyte colony-stimulating factor in leukocyte-mediated immune glomerular injury. J AmSoc Nephrol 13: 350-358, 2002
174. Freeley SJ, Coughlan AM, Popat RJ, Dunn-Walters DK, Robson MG: Granulocyte colony stimulating factor exacerbates antineutrophil cytoplasmic antibody vasculitis. Ann Rheum Dis 72: 1053-1058, 2013
175. Lord PC, Wilmoth LM, Mizel SB, McCall CE: Expression of interleukin-1 alpha and beta genes by human blood polymorphonuclear leukocytes. J Clin Invest 87: 1312-1321, 1991
176. Rastaldi MP, Ferrario F, Crippa A, Dell'Antonio G, Casartelli D, Grillo C, D'Amico G: Glomerular monocyte-macrophage features in ANCA-positive renal vasculitis and cryoglobulinemic nephritis. J Am Soc Nephrol 11: 2036-2043, 2000
177. Hahn WH, Cho BS, Kim SD, Kim SK, Kang S: Interleukin-1 cluster gene polymorphisms in childhood IgA nephropathy. Pediatr Nephrol 24: 1329-1336, 2009
178. Takemura T, Yoshioka K, Murakami K, Akano N, Okada M, Aya N, Maki S: Cellular localization of inflammatory cytokines in human glomerulonephritis. Virchows Arch 424: 459-464, 1994
179. Marucha PT, Zeff RA, Kreutzer DL: Cytokine regulation of IL-1 beta gene expression in the human polymorphonuclear leukocyte. J Immunol 145: 2932-2937, 1990
180. Tomosugi NI, Cashman SJ, Hay H, Pusey CD, Evans DJ, Shaw A, Rees AJ:Modulation of antibody-mediated glomerular injury in vivo by bacterial lipopolysaccharide, tumor necrosis factor, and IL-1. J Immunol 142: 3083-3090, 1989
181. Lebedeva TV, Singh AK: Increased responsiveness of B. cells in the murine MRL/ lpr model of lupus nephritis to interleukin-1 beta. J Am Soc Nephrol 5: 1530-1534, 1995
182. Noronha IL, Krüger C, Andrassy K, Ritz E, Waldherr R: In situ production of TNF-alpha, IL-1 beta and IL-2R in ANCA-positive glomerulonephritis. Kidney Int 43: 682-692, 1993
183. O'Brien EC, Abdulahad WH, Rutgers A, Huitema MG, O'Reilly VP, Coughlan AM, Harrington M, Heeringa P, Little MA, Hickey FB: Intermediate monocytes in ANCA vasculitis: Increased surface expression of ANCA autoantigens and IL-1b secretion in response to anti-MPO antibodies. Sci Rep 5: 11888, 2015
184. Shin MS, Kang Y, Lee N, Wahl ER, Kim SH, Kang KS, Lazova R, Kang I: Self doublestranded (ds)DNA induces IL-1b production from human monocytes by activating NLRP3 inflammasome in the presence of anti-dsDNA antibodies. J Immunol 190: 1407-1415, 2013
185. Ericson SG, Zhao Y, Gao H, Miller KL, Gibson LF, Lynch JP, Landreth KS: Interleukin- 6 production by human neutrophils after Fc-receptor cross-linking or exposure to granulocyte colony-stimulating factor. Blood 91: 2099-2107, 1998
186. Faldt J, Dahlgren C, Ridell M: Difference in neutrophil cytokine production induced by pathogenic and non-pathogenic mycobacteria. APMIS, 110: 593-600, 2002
187. Karkar AM, Smith J, Tam FW, Pusey CD, Rees AJ: Abrogation of glomerular injury in nephrotoxic nephritis by continuous infusion of interleukin-6. Kidney Int 52: 1313-1320, 1997
188. Cash H, Relle M, Menke J, Brochhausen C, Jones SA, Topley N, Galle PR, Schwarting A: Interleukin 6 (IL-6) deficiency delays lupus nephritis in MRL-Faslpr mice: the IL-6 pathway as a new therapeutic target in treatment of autoimmune kidney disease in systemic lupus erythematosus. J Rheumatol 37: 60-70, 2010
189. Suzuki H, Yasukawa K, Saito T, Narazaki M, Hasegawa A, Taga T, Kishimoto T: Serum soluble interleukin-6 receptor in MRL/lpr mice is elevated with age and mediates the interleukin-6 signal. Eur J Immunol 23: 1078-1082, 1993
190. Tang B, Matsuda T, Akira S, Nagata N, Ikehara S, Hirano T, Kishimoto T: Age-associated increase in interleukin 6 in MRL/lpr mice. Int Immunol 3: 273-278, 1991
191. Yoshioka K, Takemura T, Murakami K, Okada M, Yagi K, Miyazato H, Matsushima K, Maki S: In situ expression of cytokines in IgA nephritis. Kidney Int 44: 825-833, 1993
192. Li L, Huang L, Vergis AL, Ye H, Bajwa A, Narayan V, Strieter RM, Rosin DL, Okusa MD: IL-17 produced by neutrophils regulates IFN-gamma-mediated neutrophil migration in mouse kidney ischemia-reperfusion injury. J Clin Invest 120: 331-342, 2010
193. Moran EM, Heydrich R, Ng CT, Saber TP, McCormick J, Sieper J, Appel H, Fearon U, Veale DJ: IL-17A expression is localised to both mononuclear and polymorphonuclear synovial cell infiltrates. PLoS One 6: e24048, 2011
194. Gan PY, Steinmetz OM, Tan DS, O'Sullivan KM, Ooi JD, Iwakura Y, Kitching AR, Holdsworth SR: Th17 cells promote autoimmune anti-myeloperoxidase glomerulonephritis. J Am Soc Nephrol 21: 925-931, 2010
195. Riedel JH, Paust HJ, Krohn S, Turner JE, Kluger MA, Steinmetz OM, Krebs CF, Stahl RA, Panzer U: IL-17F promotes tissue injury in autoimmune kidney diseases. J Am Soc Nephrol 27: 3666-3677, 2016
196. Ramani K, Pawaria S, Maers K, Huppler AR, Gaffen SL, Biswas PS: An essential role of interleukin-17 receptor signaling in the development of autoimmune glomerulonephritis. J Leukoc Biol 96: 463-472, 2014
197. Wong CK, Ho CY, Li EK, Lam CW: Elevation of proinflammatory cytokine (IL-18, IL-17, IL-12) and Th2 cytokine (IL-4) concentrations in patients with systemic lupus erythematosus. Lupus 9: 589-593, 2000
198. Fortin CF, Ear T, McDonald PP: Autocrine role of endogenous interleukin-18 on inflammatory cytokine generation by human neutrophils. FASEB J 23: 194-203, 2009
199. VerriWA Jr., Cunha TM, Ferreira SH, Wei X, Leung BP, Fraser A, McInnes IB, Liew FY, Cunha FQ: IL-15mediates antigen-induced neutrophil migration by triggering IL-18 production. Eur J Immunol 37: 3373-3380, 2007
200. Menke J, Bork T, Kutska B, Byrne KT, Blanfeld M, Relle M, Kelley VR, Schwarting A: Targeting transcription factor Stat4 uncovers a role for interleukin-18 in the pathogenesis of severe lupus nephritis in mice. Kidney Int 79: 452-463, 2011
201. Hewins P, Morgan MD, Holden N, Neil D, Williams JM, Savage CO, Harper L: IL-18 is upregulated in the kidney and primes neutrophil responsiveness in ANCA-associated vasculitis. Kidney Int 69: 605-615, 2006
202. Koenig KF, Groeschl I, Pesickova SS, Tesar V, Eisenberger U, Trendelenburg M: Serum cytokine profile in patients with active lupus nephritis. Cytokine 60: 410-416, 2012
203. Chen DY, Hsieh CW, Chen KS, Chen YM, Lin FJ, Lan JL: Association of interleukin-18 promoter polymorphisms with WHO pathological classes and serum IL-18 levels in Chinese patients with lupus nephritis. Lupus 18: 29-37, 2009
204. Leng L, Chen L, Fan J, Greven D, Arjona A, Du X, Austin D, Kashgarian M, Yin Z, Huang XR, Lan HY, Lolis E, Nikolic-Paterson D, Bucala R: A small-molecule macrophage migration inhibitory factor antagonist protects against glomerulonephritis in lupusprone NZB/NZW F1 and MRL/lpr mice. J Immunol 186: 527-538, 2011
205. Lan HY, Yang N, Nikolic-Paterson DJ, Yu XQ, Mu W, Isbel NM, Metz CN, Bucala R, Atkins RC: Expression of macrophage migration inhibitory factor in human glomerulonephritis. Kidney Int 57: 499-509, 2000
206. McColl SR, Paquin R, Ménard C, Beaulieu AD:Human neutrophils produce high levels of the interleukin 1 receptor antagonist in response to granulocyte/macrophage colony- stimulating factor and tumor necrosis factor alpha.JExpMed176: 593-598, 1992
207. Tang WW, Feng L, Vannice JL, Wilson CB: Interleukin-1 receptor antagonist ameliorates experimental anti-glomerular basement membrane antibody-associated glomerulonephritis. J Clin Invest 93: 273-279, 1994
208. Brugos B, Kiss E, Dul C, Gubisch W, Szegedi G, Sipka S, Zeher M: Measurement of interleukin- 1 receptor antagonist in patients with systemic lupus erythematosus could predict renal manifestation of the disease. Hum Immunol 71: 874-877, 2010
209. Glowacka E, Banasik M, Lewkowicz P, Tchorzewski H: The effect of LPS on neutrophils frompatients with high risk of type 1 diabetes mellitus in relation to IL-8, IL-10 and IL-12 production and apoptosis in vitro. Scand J Immunol 55: 210-217, 2002
210. De Santo C, Arscott R, Booth S, Karydis I, Jones M, Asher R, Salio M, Middleton M, Cerundolo V: Invariant NKT cells modulate the suppressive activity of IL-10-secreting neutrophils differentiated with serum amyloid A. Nat Immunol 11: 1039-1046, 2010
211. Reglier H, Arce-Vicioso M, Fay M, Gougerot-Pocidalo MA, Chollet-Martin S: Lack of IL-10 and IL-13 production by human polymorphonuclear neutrophils. Cytokine 10: 192-198, 1998
212. Davey MS, Tamassia N, Rossato M, Bazzoni F, Calzetti F, Bruderek K, Sironi M, Zimmer L, Bottazzi B, Mantovani A, Brandau S, Moser B, Eberl M, Cassatella MA: Failure to detect production of IL-10 by activated human neutrophils. Nat Immunol 12: 1017-1018, author reply 1018-1020, 2011
213. Schotte H, Willeke P, Becker H, Poggemeyer J, Gaubitz M, Schmidt H, Schlüter B: Association of extended interleukin- 10 promoter haplotypes with disease susceptibility and manifestations in German patients with systemic lupus erythematosus. Lupus 23: 378-385, 2014
214. Brandt E, Woerly G, Younes AB, Loiseau S, Capron M: IL-4 production by human polymorphonuclear neutrophils. J Leukoc Biol 68: 125-130, 2000
215. Saleem S, Dai Z, Coelho SN, Konieczny BT, Assmann KJ, Baddoura FK, Lakkis FG: IL-4 is an endogenous inhibitor of neutrophil influx and subsequent pathology in acute antibody-mediated inflammation. J Immunol 160: 979-984, 1998
216. Ifuku M, Miyake K, Watanebe M, Ito K, Abe Y, Sasatomi Y, Ogahara S, Hisano S, Sato H, Saito T, Nakashima H: Various roles of Th cytokine mRNA expression in different forms of glomerulonephritis. Am J Nephrol 38: 115-123, 2013
217. Grotendorst GR, Smale G, Pencev D: Production of transforming growth factor beta by human peripheral blood monocytes and neutrophils. J Cell Physiol 140: 396-402, 1989
218. Lianos EA, Orphanos V, Cattell V, Cook T, Anagnou N:Glomerular expression and cell origin of transforming growth factor-beta 1 in anti-glomerular basement membrane disease. Am J Med Sci 307: 1-5, 1994
219. Goumenos DS, Tsakas S, El Nahas AM, Alexandri S, Oldroyd S, Kalliakmani P, Vlachojannis JG: Transforming growth factor- beta(1) in the kidney and urine of patients with glomerular disease and proteinuria. Nephrol Dial Transplant 17: 2145-2152, 2002
220. Bliss SK, Marshall AJ, Zhang Y, Denkers EY: Human polymorphonuclear leukocytes produce IL-12, TNF-alpha, and the chemokines macrophage-inflammatory protein- 1 alpha and -1 beta in response to Toxoplasma gondii antigens. J Immunol 162: 7369-7375, 1999
221. Tsai CY, Wu TH, Yu CL, Tsai YY, Chou CT: Decreased IL-12 production by polymorphonuclear leukocytes in patients with active systemic lupus erythematosus. Immunol Invest 31: 177-189, 2002
222. Schwarting A, Tesch G, Kinoshita K, Maron R, Weiner HL, Kelley VR: IL-12 drives IFNgamma- dependent autoimmune kidney disease in MRL-Fas(lpr) mice. J Immunol 163: 6884-6891, 1999
223. Kikawada E, Lenda DM, Kelley VR: IL-12 deficiency in MRL-Fas(lpr) mice delays nephritis and intrarenal IFN-gamma expression, and diminishes systemic pathology. J Immunol 170: 3915-3925, 2003
224. Tucci M, Lombardi L, Richards HB, Dammacco F, Silvestris F: Overexpression of interleukin-12 and T helper 1 predominance in lupus nephritis. Clin Exp Immunol 154: 247-254, 2008
225. Herber D, Brown TP, Liang S, Young DA, Collins M, Dunussi-Joannopoulos K: IL-21 has a pathogenic role in a lupus-prone mouse model and its blockade with IL-21R. Fc reduces disease progression. J Immunol 178: 3822-3830, 2007
226. Rinchai D, Khaenam P, Kewcharoenwong C, Buddhisa S, Pankla R, Chaussabel D, Bancroft GJ, Lertmemongkolchai G: Production of interleukin- 27 by human neutrophils regulates their function during bacterial infection. Eur J Immunol 42: 3280-3290, 2012
227. Summers SA, Phoon RK, Ooi JD, Holdsworth SR, Kitching AR: The IL-27 receptor has biphasic effects in crescentic glomerulonephritis mediated through Th1 responses.AmJ Pathol 178: 580-590, 2011
228. Shirafuji N, Matsuda S, Ogura H, Tani K, Kodo H, Ozawa K, Nagata S, Asano S, Takaku F: Granulocyte colony-stimulating factor stimulates human mature neutrophilic granulocytes to produce interferonalpha. Blood 75: 17-19, 1990
229. Denny MF, Yalavarthi S, Zhao W, Thacker SG, Anderson M, Sandy AR, McCune WJ, Kaplan MJ: A distinct subset of proinflammatory neutrophils isolated from patients with systemic lupus erythematosus induces vascular damage and synthesizes type I IFNs. J Immunol 184: 3284-3297, 2010
230. Liu Z, Bethunaickan R, Huang W, Ramanujam M, Madaio MP, Davidson A: IFN-a confers resistance of systemic lupus erythematosus nephritis to therapy in NZB/ W F1 mice. J Immunol 187: 1506-1513, 2011
231. Liu Z, Bethunaickan R, Huang W, Lodhi U, Solano I, Madaio MP, Davidson A: Interferon- a accelerates murine systemic lupus erythematosus in a T cell-dependent manner. Arthritis Rheum 63: 219-229, 2011
232. Markowitz GS, Nasr SH, Stokes MB, D'Agati VD: Treatment with IFN-alpha, -beta, or -gamma is associated with collapsing focal segmental glomerulosclerosis. Clin J Am Soc Nephrol 5: 607-615, 2010
233. Obermoser G, Pascual V: The interferonalpha signature of systemic lupus erythematosus. Lupus 19: 1012-1019, 2010
234. Coit P, Yalavarthi S, Ognenovski M, Zhao W, Hasni S, Wren JD, Kaplan MJ, Sawalha AH: Epigenome profiling reveals significant DNA demethylation of interferon signature genes in lupus neutrophils. J Autoimmun 58: 59-66, 2015
235. Ytterberg SR, Schnitzer TJ: Serum interferon levels in patients with systemic lupus erythematosus. Arthritis Rheum 25: 401-406, 1982
236. Bengtsson AA, Sturfelt G, Truedsson L, Blomberg J, Alm G, Vallin H, Rönnblom L: Activation of type I interferon system in systemic lupus erythematosus correlates with disease activity but not with antiretroviral antibodies. Lupus 9: 664-671, 2000
237. Evans R, Rudd P, Bass P, Harber M: Tip variant focal segmental glomerulosclerosis associated with interferon-beta treatment of multiple sclerosis. BMJ Case Reports, 2014, 2014.
238. Wallbach M, Gröne HJ, Kitze B, Müller GA, Koziolek MJ: Nephrotic syndrome in a multiple sclerosis patient receiving longterm interferon beta therapy. Am J Kidney Dis 61: 786-789, 2013
239. Ethuin F, Gérard B, Benna JE, Boutten A, Gougereot-Pocidalo MA, Jacob L, Chollet-Martin S: Human neutrophils produce interferon gamma upon stimulation by interleukin-12. Lab Invest 84: 1363-1371, 2004
240. Schwarting A, Wada T, Kinoshita K, Tesch G, Kelley VR: IFN-gamma receptor signaling is essential for the initiation, acceleration, and destruction of autoimmune kidney disease in MRL-Fas(lpr) mice. J Immunol 161: 494-503, 1998
241. Haas C, Ryffel B, Le Hir M: IFN-gamma receptor deletion prevents autoantibody production and glomerulonephritis in lupus- prone (NZB x NZW)F1mice. J Immunol 160: 3713-3718, 1998
242. Jacob CO, van der Meide PH, McDevitt HO: In vivo treatment of (NZB X NZW)F1 lupus-like nephritis with monoclonal antibody to gamma interferon. J ExpMed 166: 798-803, 1987
243. Kim K, Cho SK, Sestak A, Namjou B, Kang C, Bae SC: Interferon-gamma gene polymorphisms associated with susceptibility to systemic lupus erythematosus. Ann Rheum Dis 69: 1247-1250, 2010
244. Dubravec DB, Spriggs DR, Mannick JA, Rodrick ML: Circulating human peripheral blood granulocytes synthesize and secrete tumor necrosis factor alpha. Proc Natl Acad Sci USA 87: 6758-6761, 1990
245. Bazzoni F, Cassatella MA, Laudanna C, Rossi F: Phagocytosis of opsonized yeast induces tumor necrosis factor-alpha mRNA accumulation and protein release by human polymorphonuclear leukocytes. J Leukoc Biol 50: 223-228, 1991
246. Parks CG, Pandey JP, Dooley MA, Treadwell EL, St Clair EW, Gilkeson GS, Feghali-Bostwick CA, Cooper GS: Genetic polymorphisms in tumor necrosis factor (TNF)-alpha and TNF-beta in a population-based study of systemic lupus erythematosus: Associations and interaction with the interleukin-1alpha- 889 C/T polymorphism. Hum Immunol 65: 622-631, 2004
247. Puga I, Cols M, Barra CM, He B, Cassis L, Gentile M, Comerma L, Chorny A, Shan M, Xu W, Magri G, Knowles DM, Tam W, Chiu A, Bussel JB, Serrano S, Lorente JA, Bellosillo B, Lloreta J, Juanpere N, Alameda F, Baró T, de Heredia CD, Torán N, Català A, Torrebadell M, Fortuny C, Cusí V, Carreras C, Diaz GA, Blander JM, Farber CM, Silvestri G, Cunningham-Rundles C, Calvillo M, Dufour C, Notarangelo LD, Lougaris V, Plebani A, Casanova JL, Ganal SC, Diefenbach A, Aróstegui JI, Juan M, Yagüe J, Mahlaoui N, Donadieu J, Chen K, Cerutti A: B cell-helper neutrophils stimulate the diversification and production of immunoglobulin in themarginal zone of the spleen. Nat Immunol 13: 170-180, 2011
248. Huard B, McKee T, Bosshard C, Durual S, Matthes T, Myit S, Donze O, Frossard C, Chizzolini C, Favre C, Zubler R, Guyot JP, Schneider P, Roosnek E: APRIL secreted by neutrophils binds to heparan sulfate proteoglycans to create plasma cell niches in human mucosa. J Clin Invest 118: 2887-2895, 2008
249. Vincent FB, Northcott M, Hoi A, Mackay F, Morand EF: Association of serum B cell activating factor from the tumour necrosis factor family (BAFF) and a proliferation-inducing ligand (APRIL) with central nervous system and renal disease in systemic lupus erythematosus. Lupus 22: 873-884, 2013
250. Scapini P, Nardelli B, Nadali G, Calzetti F, Pizzolo G, Montecucco C, Cassatella MA: G-CSF-stimulated neutrophils are a prominent source of functional BLyS. J Exp Med 197: 297-302, 2003
251. Fletcher CA, Groom JR, Woehl B, Leung H, Mackay C, Mackay F: Development of autoimmune nephritis in genetically asplenic and splenectomized BAFF transgenic mice. J Autoimmun 36: 125-134, 2011
252. Ramanujam M, Bethunaickan R, Huang W, Tao H, Madaio MP, Davidson A: Selective blockade of BAFF for the prevention and treatment of systemic lupus erythematosus nephritis inNZM2410mice. Arthritis Rheum 62: 1457-1468, 2010
253. Zhao LD, Li Y, SmithMF Jr., Wang JS, Zhang W, Tang FL, Tian XP, Wang HY, Zhang FC, Ba DN, He W, Zhang X: Expressions of BAFF/BAFF receptors and their correlation with disease activity in Chinese SLE patients. Lupus 19: 1534-1549, 2010
254. Tarzi RM, Sharp PE, McDaid JP, Fossati-Jimack L, Herbert PE, Pusey CD, Cook HT, Warrens AN: Mice with defective Fas ligand are protected from crescentic glomerulonephritis. Kidney Int 81: 170-178, 2012
255. Cui JH, Qiao Q, Guo Y, Zhang YQ, Cheng H, He FR, Zhang J: Increased apoptosis and expression of Fas L, Bax and caspase-3 in human lupus nephritis class II and IV. J Nephrol 25: 255-261, 2012
256. Nguyen V, Cudrici C, Zernetkina V, Niculescu F, Rus H, Drachenberg C, Rus V: TRAIL, DR4 and DR5 are upregulated in kidneys from patients with lupus nephritis and exert proliferative and proinflammatory effects. Clin Immunol 132: 32-42, 2009